Acknowledgement
Supported by : Kyung Hee University
References
- Jesus MD, Wurm FM. 2011. Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors. Eur. J. Pharm. Biopharm. 78: 184-188. https://doi.org/10.1016/j.ejpb.2011.01.005
- Durocher Y, Butler, M. 2009. Expression systems for therapeutic glycoprotein production. Curr. Opin. Biotechnol. 20: 700-707. https://doi.org/10.1016/j.copbio.2009.10.008
- Dietmair S, Nielsen LK, Timmins NE. 2010. Engineering a mammalian super producer. J. Chem. Technol. Biotechnol. 86: 905-914. https://doi.org/10.1002/jctb.2576
- Noh SM, Sathyamurthy M, Lee GM. 2013. Development of recombinant Chinese hamster ovary cell lines for therapeutic protein production. Curr Opin. Chem. Eng. 2: 391-397. https://doi.org/10.1016/j.coche.2013.08.002
- Baldi L, Hacker DL, Adam M, Wurm FM. 2007. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of art and future perspectives. Biotechnol. Lett. 29: 677-684. https://doi.org/10.1007/s10529-006-9297-y
- Bertschinger M, Schertenleib A, Cavey J, Hacker DL, Wurm FM. 2008. The kinetics of polyethylenimine-mediated transfection in suspension cultures of Chinese hamster ovary cells. Mol Biotechnol. 40: 136-143. https://doi.org/10.1007/s12033-008-9069-0
- Steger K, Brady J, Wang W, Duskin M, Donato K, Peshwa M. 2015. CHO-S antibody titers >1 gram/liter using flow electroporation-mediated gene expression followed by rapid migration to high-yield stable cell lines. J. Biomol. Screen. 20: 545-551. https://doi.org/10.1177/1087057114563494
- Cervera L, Fuenmayer J, Gonzalez-Dominguez I, Gutierrez-Granados S, Segura MM, Godia F. 2015. Selection and optimization enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures. Appl. Microbiol. Biotechnol. 99: 9935-9949. https://doi.org/10.1007/s00253-015-6842-4
- Melkonyan H, Sorg C, Klempt M. 1996. Electroporation efficiency in mammalian cells is increased by dimethyl sulfoxide (DMSO). Nucleic. Acids Res. 24: 4356-4357. https://doi.org/10.1093/nar/24.21.4356
- Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF. 2009. High-level protein expression in scalable CHO transient transfection. Biotechnol. Bioeng. 103: 542-551. https://doi.org/10.1002/bit.22265
- Daly TJ, Fandl JP, Papadopoulos NJ. 2006. Fusion protein capable of binding VEGF. US Patent publication No 7087411B2.
- Yoon J, Baek K, Byun T, Park J. 2014. Expression vector animal cells. US Patent Publication No 20140038233.
- Ciudad CJ, Urlaub G, Chasin LA. 1988. Deletion analysis of the Chinese hamster dihydrofolate reductase gene promoter. J. Biol. Chem. 263: 16274-16282. https://doi.org/10.1016/S0021-9258(18)37589-6
- Paredes V, Park JS, Jeong Y, Yoon J, Baek K. 2013. Unstable expression of recombinant antibody during long-term culture of CHO cells is accompanied by histone H3 hypoacetylation. Biotechnol. Lett. 35: 987-993. https://doi.org/10.1007/s10529-013-1168-8
Cited by
- Efficient production process of bioactive recombinant human leukemia inhibitory factor in Chinese hamster ovary cells vol.176, 2019, https://doi.org/10.1016/j.pep.2020.105744